CERE
Cerevel Therapeutics Holdings, Inc.
CEO and Chair N Anthony Coles sold $1.6M of Cerevel Therapeutics Holdings, Inc.
Sold$1,573,434
$31.47Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Mon, May 8 close, $32.74
- +1.0%
- S&P 500, same days
- +5.8%
Measured over 30 trading days, to the Jun 21 close.
Traded Thu, May 4. Filed Mon, May 8, 12:24 PM ET, during the session. Returns use the May 8 close and the Jun 21 close. Not investment advice.